Clinical Trials Logo

Patient-Controlled Analgesia clinical trials

View clinical trials related to Patient-Controlled Analgesia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06301932 Completed - Epidural Analgesia Clinical Trials

The Effectiveness and Outcomes of Epidural Analgesia in Patients Undergoing Open Hepatectomy

Start date: January 1, 2006
Phase:
Study type: Observational

This observational study is to compare the effectiveness and outcomes of epidural analgesia in patients undergoing open hepatectomy: A propensity score matching analysis. The main question is: What is the superior method of pain control in open hepatectomy: epidural analgesia or intravenous PCA?

NCT ID: NCT06000137 Completed - Clinical trials for Patient-controlled Analgesia

The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

Laryngeal cancer is one of the most common tumors in otolaryngology. In China, it accounts for 1-5% of all malignancies and has an incidence of 1.13 per 100,000. Surgical resection is the most important treatment for patients who are not candidates for chemoradiotherapy or refuse chemoradiotherapy. The types of surgery include total and partial laryngectomy. Patients with laryngeal cancer often face multiple physical and psychiatric changes after surgery, such as daily large sputum production accompanied by cough, cleaning care of the air incision, fatigue, and sleep disturbances. Some patients do not actively exclude secretions due to pain, and the formation of sputum plugs causes lung inflammation, which is not conducive to postoperative recovery. Good postoperative pain management is beneficial to shorten the length of hospital stay and reduce mortality. Sufentanil is most commonly used for postoperative analgesia and has good analgesic effect, but there are some adverse effects, such as dizziness, nausea and vomiting, urinary retention, skin itching, respiratory depression, etc. As a new type of analgesic, dezocine has been widely used in clinical practice with few adverse reactions to the respiratory and circulatory system, and its application to postoperative analgesia can significantly improve the immune activity. At present, there are not many studies on continuous analgesia of dezocine, mostly single-dose analgesia studies, this study for different doses of dezocine for the postoperative analgesic effect of laryngeal cancer patients, compared with the current classic opioid analgesics, to provide a new scheme for clinical medication.

NCT ID: NCT05822492 Completed - Anesthesia Clinical Trials

Anterior Quadratus Lumborum Block Versus Erector Spina Plane Block in Percutaneous Nephrolithotomy Surgery

Start date: April 20, 2023
Phase:
Study type: Observational

In this study, it was aimed to evaluate the effects of anterior quadratus lumborum block (QLB3) and Erector Spina Plane Block (ESPB) on postoperative acute pain scores and opioid consumption in the first 24 hours in Percutaneous Nephrolithotomy Surgery

NCT ID: NCT05191966 Completed - Anesthesia Clinical Trials

Subcostal Approach to Anterior Quadratus Block Versus Thoracic Paravertebral Block for Laparoscopic Nephrectomy

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

In this study, it was aimed to evaluate the effects of subcostal anterior quadratus lumborum block (S-QLB3) and thoracic paravertebral block (TPVB) on postoperative acute pain scores and opioid consumption in the first 24 hours after laparoscopic nephrectomy surgery.

NCT ID: NCT05191953 Completed - Anesthesia Clinical Trials

ESPB vs.Combination of ESPB and Superficial PIPB in Cardiac Surgery

Start date: January 26, 2022
Phase: N/A
Study type: Interventional

Cardiac surgery is associated with significant postoperative pain. Pain control is an essential part of enhanced recovery protocols. The aim of this study is to evaluate and compare the analgesic efficacies of erector spinae plane block (ESPB) and the combination of ESPB and superficial parasternal intercostal plane block (PIPB) in patients undergoing elective cardiac surgery.

NCT ID: NCT04135157 Completed - Chronic Pain Clinical Trials

Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the analgesic effects of pectoralis nerve block (PECS II) and erector spinae plane block (ESP) in patients having segmental mastectomy and sentinel lymph node biopsy (SLNB). Each one-third of patients will have ESP block and pectoralis nerve block (PECS II) 30 min before general anesthesia , while other one-third of patients will have only general anesthesia.

NCT ID: NCT04082039 Completed - Clinical trials for Patient-controlled Analgesia

Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH)

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the dual channel intravenous patient-controlled analgesia (IV-PCA) with single channel elastomeric pump (only one channel of dual channel pump is used for blinding and the other channel is filled with same volume of saline) in patients undergoing total laparoscopic hysterectomy, in terms of quality of recovery, efficacy of postoperative pain, drug consumption, adverse event, and patient subjective satisfaction.

NCT ID: NCT03221491 Completed - Clinical trials for Patient-Controlled Analgesia

Comparison of Patient-Controlled Analgesia With Different Background Infusion

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

In this study, the investigators investigated the efficacy, usefulness and analgesic consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone without background infusion, bolus dose with low background infusion and bolus dose with high background infusion to evaluate postoperative analgesia for patients after laparoscopic colorectal surgery.

NCT ID: NCT00564603 Completed - Postoperative Pain Clinical Trials

Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy

DTMPCA
Start date: August 2007
Phase: Phase 4
Study type: Interventional

Dexamethasone has been recognized as an antiemetic agent after surgeries, and the combination of dexamethasone and tramadol remained stable in solution up to 5 days. In addition, i.v. basal infusion of tramadol is a certified technique in postoperative pain management. We purposed that combined administration of dexamethasone and tramadol adjunct to i.v. morphine is an effective way in treating postoperative pain.